IT201900022203A1 - Proteine uk 114 da salmone per uso nella terapia, nella diagnostica e nella prevenzione di neoplasie maligne - Google Patents
Proteine uk 114 da salmone per uso nella terapia, nella diagnostica e nella prevenzione di neoplasie maligneInfo
- Publication number
- IT201900022203A1 IT201900022203A1 IT102019000022203A IT201900022203A IT201900022203A1 IT 201900022203 A1 IT201900022203 A1 IT 201900022203A1 IT 102019000022203 A IT102019000022203 A IT 102019000022203A IT 201900022203 A IT201900022203 A IT 201900022203A IT 201900022203 A1 IT201900022203 A1 IT 201900022203A1
- Authority
- IT
- Italy
- Prior art keywords
- neoplasies
- salmon
- diagnostics
- malignant
- therapy
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1706—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from fish
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/70—Vectors or expression systems specially adapted for E. coli
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Marine Sciences & Fisheries (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Chemical & Material Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Plant Pathology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Enzymes And Modification Thereof (AREA)
Priority Applications (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT102019000022203A IT201900022203A1 (it) | 2019-11-26 | 2019-11-26 | Proteine uk 114 da salmone per uso nella terapia, nella diagnostica e nella prevenzione di neoplasie maligne |
CA3159292A CA3159292A1 (en) | 2019-11-26 | 2020-11-23 | Uk 114 salmon proteins for use in the treatment, diagnosis and prevention of malignant tumours |
MX2022006278A MX2022006278A (es) | 2019-11-26 | 2020-11-23 | Proteinas de salmon uk 114 para uso en el tratamiento, diagnostico y prevencion de tumores malignos. |
CN202080081596.6A CN114761034A (zh) | 2019-11-26 | 2020-11-23 | Uk 114鲑鱼蛋白用于治疗、诊断和预防恶性肿瘤 |
JP2022530848A JP2023504241A (ja) | 2019-11-26 | 2020-11-23 | 悪性腫瘍の治療、診断および予防に使用するためのuk114サケタンパク質 |
EP20820795.1A EP4065154A1 (en) | 2019-11-26 | 2020-11-23 | Uk 114 salmon proteins for use in the treatment, diagnosis and prevention of malignant tumours |
US17/756,262 US20230000946A1 (en) | 2019-11-26 | 2020-11-23 | Uk 114 salmon proteins for use in the treatment, diagnosis and prevention of malignant tumours |
PCT/EP2020/083069 WO2021105059A1 (en) | 2019-11-26 | 2020-11-23 | Uk 114 salmon proteins for use in the treatment, diagnosis and prevention of malignant tumours |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT102019000022203A IT201900022203A1 (it) | 2019-11-26 | 2019-11-26 | Proteine uk 114 da salmone per uso nella terapia, nella diagnostica e nella prevenzione di neoplasie maligne |
Publications (1)
Publication Number | Publication Date |
---|---|
IT201900022203A1 true IT201900022203A1 (it) | 2021-05-26 |
Family
ID=70009105
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IT102019000022203A IT201900022203A1 (it) | 2019-11-26 | 2019-11-26 | Proteine uk 114 da salmone per uso nella terapia, nella diagnostica e nella prevenzione di neoplasie maligne |
Country Status (8)
Country | Link |
---|---|
US (1) | US20230000946A1 (it) |
EP (1) | EP4065154A1 (it) |
JP (1) | JP2023504241A (it) |
CN (1) | CN114761034A (it) |
CA (1) | CA3159292A1 (it) |
IT (1) | IT201900022203A1 (it) |
MX (1) | MX2022006278A (it) |
WO (1) | WO2021105059A1 (it) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1996002567A1 (en) | 1994-07-14 | 1996-02-01 | Zetesis S.P.A. | Proteins from mammalian liver and their use in oncology |
WO1996014340A1 (en) * | 1994-11-04 | 1996-05-17 | Zetesis S.P.A. | Antibodies against allogenic and xenogenic proteins, their use in diagnosis and therapy and methods for the determination thereof |
WO2000063368A1 (en) | 1999-04-15 | 2000-10-26 | Zetesis S.P.A. | Recombinant protein uk114 and its use in therapy and diagnostics |
WO2018109096A1 (en) * | 2016-12-16 | 2018-06-21 | Alberto Bartorelli Cusani | Novel recombinant protein uk 114 in stable polymer form for use in the treatment, diagnosis and prevention of malignant solid and systemic tumours |
-
2019
- 2019-11-26 IT IT102019000022203A patent/IT201900022203A1/it unknown
-
2020
- 2020-11-23 WO PCT/EP2020/083069 patent/WO2021105059A1/en unknown
- 2020-11-23 EP EP20820795.1A patent/EP4065154A1/en active Pending
- 2020-11-23 MX MX2022006278A patent/MX2022006278A/es unknown
- 2020-11-23 CA CA3159292A patent/CA3159292A1/en active Pending
- 2020-11-23 JP JP2022530848A patent/JP2023504241A/ja active Pending
- 2020-11-23 US US17/756,262 patent/US20230000946A1/en active Pending
- 2020-11-23 CN CN202080081596.6A patent/CN114761034A/zh active Pending
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1996002567A1 (en) | 1994-07-14 | 1996-02-01 | Zetesis S.P.A. | Proteins from mammalian liver and their use in oncology |
WO1996014340A1 (en) * | 1994-11-04 | 1996-05-17 | Zetesis S.P.A. | Antibodies against allogenic and xenogenic proteins, their use in diagnosis and therapy and methods for the determination thereof |
WO2000063368A1 (en) | 1999-04-15 | 2000-10-26 | Zetesis S.P.A. | Recombinant protein uk114 and its use in therapy and diagnostics |
WO2018109096A1 (en) * | 2016-12-16 | 2018-06-21 | Alberto Bartorelli Cusani | Novel recombinant protein uk 114 in stable polymer form for use in the treatment, diagnosis and prevention of malignant solid and systemic tumours |
EP3554639A1 (en) | 2016-12-16 | 2019-10-23 | Alberto Bartorelli Cusani | Novel recombinant protein uk 114 in stable polymer form for use in the treatment, diagnosis and prevention of malignant solid and systemic tumours |
Non-Patent Citations (12)
Title |
---|
BARTORELLI A ET AL., INT J ONCOL., vol. 8, no. 3, March 1996 (1996-03-01), pages 543 - 8 |
BARTORELLI ET AL., J. TUMOR AND MARKER ONCOLOGY, vol. 9, 1994, pages 37 |
BUSSOLATI G ET AL., INT J ONCOL., vol. 10, no. 4, April 1997 (1997-04-01), pages 779 - 85 |
CECILIANI F. ET AL., FEBS LETTERS, vol. 393, 1996, pages 147 - 150 |
COLOMBO I ET AL., BIOCHIM. BIOPHYS. ACTA, vol. 1442, 1998, pages 49 - 59 |
DHAWAN L ET AL., MOL. CELL. BIOL., vol. 32, 2012, pages 3768 - 3775 |
ERNST DC ET AL., J. BACTERIOLOGY, vol. 196, no. 18, 2014, pages 3335 - 3342 |
FLYNN JM ET AL., MOL. MICROBIOL., vol. 89, no. 4, 2013, pages 751 - 759 |
LAMBRECHT JA ET AL., J.BIOL. CHEM., vol. 287, 2012, pages 34401 - 34407 |
MYSTINIENE ET AL., BIOCONJUGATE CHEM., vol. 14, 2003, pages 1243 - 1252 |
NIEHAUS TD ET AL., BMC GENOMICS, vol. 16, 2015, pages 382 |
RACCA S ET AL: "Growth inhibition of DMBA-induced rat mammary carcinomas by UK 114", VIRCHOWS ARCHIV, SPRINGER INTERNATIONAL, BERLIN, DE, vol. 431, no. 5, 1 November 1997 (1997-11-01), pages 323 - 328, XP002267961, ISSN: 0945-6317, DOI: 10.1007/S004280050106 * |
Also Published As
Publication number | Publication date |
---|---|
JP2023504241A (ja) | 2023-02-02 |
WO2021105059A1 (en) | 2021-06-03 |
CN114761034A (zh) | 2022-07-15 |
MX2022006278A (es) | 2022-08-15 |
EP4065154A1 (en) | 2022-10-05 |
US20230000946A1 (en) | 2023-01-05 |
CA3159292A1 (en) | 2021-06-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CL2020002043A1 (es) | Métodos y composiciones para la entrega de proteínas terapeuticas. | |
EP4295846A3 (en) | Heteroarylaminopyrimidine amide autophagy inhibitors and methods of use thereof | |
MX2021013661A (es) | Inhibidores de la autofagia de fenilaminopirimidina amida y metodos de uso de estos. | |
WO2019083990A3 (en) | IMAGING AND RADIOTHERAPEUTICS AGENTS TARGETING FIBROBLAST-ACTIVATION PROTEIN-α (FAP-α) | |
BR112018008326A2 (pt) | composições e métodos para o tratamento de câncer | |
MX2022007994A (es) | Derivados de arilciclohexilamina y su uso en el tratamiento de trastornos psiquiátricos. | |
BR112019017403A2 (pt) | composições e métodos para o tratamento de câncer | |
PH12020551716A1 (en) | Anti-ror antibody constructs | |
AU2016304856A8 (en) | Mechanism of resistance to BET bromodomain inhibitors | |
EP3749315A4 (en) | ALPHA-POLYGLUTAMATED RALTITREXED AND USES THEREOF | |
EP3768698A4 (en) | METHODS AND COMPOSITIONS COMPRISING TUMOR SUPPRESSIVE GENE THERAPY AND CD122/CD132 AGONISTS FOR THE TREATMENT OF CANCER | |
MX2021015628A (es) | Inhibidores de la autofagia de la amida aminopirimidina y sus metodos de uso. | |
BR112021016056A2 (pt) | Anticorpos de claudina 6 e usos dos mesmos | |
WO2017151860A8 (en) | Human kynureninase enzyme variants having improved pharmacological properties | |
MX2020010932A (es) | Enzimas quinureninasa humanas y sus usos. | |
EP3915985A4 (en) | PYRROLOPYRIDINE DERIVATIVE AND ITS USE IN THE PREVENTION AND TREATMENT OF PROTEIN KINASE RELATED DISEASE | |
WO2017143115A3 (en) | Enhancing the therapeutic activity of an immune checkpoint inhibitor | |
EP4342544A3 (en) | Enhancing the therapeutic activity of an immune checkpoint inhibitor | |
EP4013445A4 (en) | THERAPEUTIC PROTEIN COMPOSITIONS AND METHODS | |
WO2020180712A8 (en) | Anti-tnfr2 antibodies and uses thereof | |
IL290656A (en) | Lorbinectadine in the treatment of malignant mesothelioma | |
IL280218A (en) | Methods for the treatment of HFPEF using dapagliflozin and compounds containing it | |
IT201900022203A1 (it) | Proteine uk 114 da salmone per uso nella terapia, nella diagnostica e nella prevenzione di neoplasie maligne | |
MX2022000263A (es) | Nuevos antigenos y metodos contra el cancer. | |
IT201700085412A1 (it) | Composizione per uso nella prevenzione e nel trattamento di patologie dell'apparato cardiovascolare |